CRINETICS PHARMACEUTICALS IN's ticker is and the CUSIP is 22663K907. A total of 2 filers reported holding CRINETICS PHARMACEUTICALS IN in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $874 | +7183.3% | 29,400 | +4100.0% | 0.00% | – |
| Q2 2023 | $12 | -89.0% | 700 | -89.7% | 0.00% | – |
| Q1 2023 | $109 | +10800.0% | 6,800 | +6700.0% | 0.00% | – |
| Q4 2022 | $1 | -100.0% | 100 | -97.6% | 0.00% | – |
| Q3 2022 | $80,000 | 0.0% | 4,100 | -4.7% | 0.00% | – |
| Q2 2022 | $80,000 | +3900.0% | 4,300 | +4200.0% | 0.00% | – |
| Q1 2022 | $2,000 | 0.0% | 100 | 0.0% | 0.00% | – |
| Q4 2021 | $2,000 | – | 100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SIMPLEX TRADING, LLC | 100 | $2,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |